ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ARMEN AGHABEGIAN P.A.

Cardiovascular Disease

253

$5,290

96
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

6%
prescriptions for brand name drugs

Avg: 28%

$21
Average prescription price

Avg: $67

HERBERT LEE MD

Cardiovascular Disease

323

$5,451

57
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

7%
prescriptions for brand name drugs

Avg: 28%

$17
Average prescription price

Avg: $67

JONATHAN TURNER M.D.

Cardiovascular Disease

281

$11.1K

111
99 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

46%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 28%

$39
Average prescription price

Avg: $67

ABDUL ABBASI MD

Cardiovascular Disease

313

$11.2K

48
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$36
Average prescription price

Avg: $67

JOSEPH GHAZAL M.D.

Cardiovascular Disease

472

$11.2K

65
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$24
Average prescription price

Avg: $67

STEVEN STRICKER MD

Cardiovascular Disease

237

$12.3K

42
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 28%

$52
Average prescription price

Avg: $67

RALPH WESSEL MD

Cardiovascular Disease

237

$12.7K

31
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 28%

$54
Average prescription price

Avg: $67

WILLIAM DISCEPOLO M.D.

Cardiovascular Disease

369

$13.6K

87
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$37
Average prescription price

Avg: $67

SHAZIA HASAN M.D.

Cardiovascular Disease

277

$13.9K

51
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 28%

$50
Average prescription price

Avg: $67

LAWRENCE RAPHAEL MD

Cardiovascular Disease

415

$15K

97
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

4%
prescriptions for brand name drugs

Avg: 28%

$36
Average prescription price

Avg: $67

DIPESHKUMAR GANDHI MD

Cardiovascular Disease

456

$15.8K

143
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 28%

$35
Average prescription price

Avg: $67

NAHEED OLSEN MD

Cardiovascular Disease

517

$16.3K

173
164 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 28%

$32
Average prescription price

Avg: $67

HOWARD BUCKLEY M.D.

Cardiovascular Disease

435

$16.7K

78
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 28%

$38
Average prescription price

Avg: $67

CALVIN WEISBERGER MD

Cardiovascular Disease

497

$17.4K

113
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 28%

$35
Average prescription price

Avg: $67

NEIL TREISTER M.D.

Cardiovascular Disease

355

$17.9K

35
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 28%

$50
Average prescription price

Avg: $67

MINISHA KOCHAR MD

Cardiovascular Disease

441

$18.1K

142
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 28%

$41
Average prescription price

Avg: $67

REZA SEPEHRDAD M.D.

Cardiovascular Disease

539

$18.5K

51
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 28%

$34
Average prescription price

Avg: $67

ASHOK KRISHNASWAMI MD

Cardiovascular Disease

441

$18.5K

128
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 28%

$42
Average prescription price

Avg: $67

WILLIAM FRENCH M.D.

Cardiovascular Disease

579

$19K

111
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

6%
prescriptions for brand name drugs

Avg: 28%

$33
Average prescription price

Avg: $67

DANIEL JUREWITZ M.D.

Cardiovascular Disease

465

$19K

65
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 28%

$41
Average prescription price

Avg: $67

ENRIQUE OSTRZEGA M.D.

Cardiovascular Disease

222

$19K

30
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 28%

$86
Average prescription price

Avg: $67

ROBERT SCHATZ M.D.

Cardiovascular Disease

551

$19.5K

218
190 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$35
Average prescription price

Avg: $67

DAVID SULCINER MD

Cardiovascular Disease

446

$19.6K

143
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 28%

$44
Average prescription price

Avg: $67

PATRICK MCGINTY MD

Cardiovascular Disease

434

$20K

71
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$46
Average prescription price

Avg: $67

WASEEMUDDIN KAZI MD

Cardiovascular Disease

567

$20.1K

136
116 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 28%

$35
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank